Co-morbidities

Jenna Skowronski , Eleanor Christenson , Kayle Shapero , et al

Read time: 21m 19s
AHA 24: 3 Trials That Will Change My Practice

Michelle Kittleson

Watch time: 10m 27s
AHA 24: The EMPEROR-Preserved Trial

Andrew JS Coats

Watch time: 4m 41s

Muthiah Vaduganathan, Orly Vardeny et al

AHA 24 Late-Breaking Discussion: REALIZE-K

Harriette Van Spall, Mikhail Kosiborod

Watch time: 22m 30s
ESC 24: MRAs in Heart Failure

Watch time: 5m 46s

Broadcast

Heart Failure
Medical Options for Advanced HFpEF/HFmrEF Patients

Biykem Bozkurt, Muthiah Vaduganathan, , et al

Watch time: 1h 1m 12s
HFA 24 Late-Breaker Wrap Up with Dr Van Spall & Dr Petrie

Harriette Van Spall, Mark Petrie

Watch time: 15m 26s

Harriette Van Spall, Mark Petrie

EP 105: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Listen time: 1h 3m 40s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer

Watch time: 1h 5m 20s
CardioNerds @AHA23: An Extended Duration Short-Interfering RNA Targeting Lp(a)

Steven E Nissen, Maryam Barkhordarian

Watch time: 9m 14s

Christiane Angermann, Javed Butler, Clyde W Yancy, et al

Watch time: 1h 4m (6 videos)

Carolyn Lam, Scott Solomon, John JV McMurray, et al

Watch time: 1:02:16 (5 videos)

Muthiah Vaduganathan

Sydney Tang et al

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 5h 14m 55s (31 videos)

Andrew JS Coats, Stefan Anker

Shelley Zieroth, Martin R Cowie, Javed Butler, et al

Watch time: 53m 14s (5 videos)

Mikhail Kosiborod, Dalane W Kitzman

Watch time: 36m 12s (5 videos)

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus et al

Muthiah Vaduganathan, Orly Vardeny et al

Broadcast

Heart Failure
Hyperkalaemia in Cardiorenal Disease

Shelley Zieroth, Clara Bonanad Lozano , Andrew Frankel, et al

Watch time: 1h 34m 52s

About

Comorbidities frequently accompany chronic heart failure, contributing to increased morbidity and mortality, and an impaired quality of life. Extreme comorbidity is significantly more common in patients with chronic heart failure due to left ventricular systolic dysfunction. The efficient management of such complexity requires the integration of general and specialist expertise.

Media

HFA 23: DAPA MODA: Dapaglifozin & Cardiac Remodelling in Chronic HF

Domingo Figal

Watch time: 8m 47s
HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial

Robert Mentz, Harriette Van Spall

Watch time: 5m 48s

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus et al

ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s

Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al

Watch time: 2h 22m (10 videos)

Shelley Zieroth

Watch time: 3m 59s (1 video)
Radcliffe & CardioNerds @AHA22: IRONMAN: Intravenous Ferric Derisomaltose in HF With Reduced EF

Rawan Amir, Paul Kalra

Watch time: 18m 58s

Broadcast

Heart Failure
Hyperkalaemia in Cardiorenal Disease

Shelley Zieroth, Clara Bonanad Lozano , Andrew Frankel, et al

Watch time: 1h 34m 52s

Paul Kalra

Watch time: 12m 41s (2 videos)

Christiane Angermann, Javed Butler, Clyde W Yancy, et al

Watch time: 1h 4m (6 videos)

Broadcast

Heart Failure

MI/ACS
Valsartan Sacubitril: Has our PARADIGM shifted?

Giuseppe Rosano, Richard Henry P Tiongco, Rungroj Krittayaphong, et al

Watch time: 53m 45s

Media

Shelley Zieroth, Martin R Cowie, Javed Butler, et al

Watch time: 53m 14s (5 videos)

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 5h 14m 55s (31 videos)

Mikhail Kosiborod, Dalane W Kitzman

Watch time: 36m 12s (5 videos)
HFA 2020: Prospective analysis of DAPA-HF

Watch time: 6m 52s
HFA 2020: Dapagliflozin and diuretic use in patients with HFrEF in DAPA-HF

Alice Jackson

Watch time: 6m 56s
ESC 2020: Commentary on the EMPEROR-Reduced Study — Dr Giuseppe Galati

Giuseppe Galati

Watch time: 10m 13s
ACC 2021 Discussion: Benefits of SGLT1/2 Inhibition Across the Full Spectrum of EF, Including HFpEF

Deepak L Bhatt, Harriette Van Spall

Watch time: 16m 6s
The PRESERVED-HF Study

Mikhail Kosiborod

Watch time: 12m 4s
EMPATROPISM FE: Effects of Empagliflozin on iron metabolism in non-diabetic

Christiane Angermann

Watch time: 22m 15s
ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

Watch time: 22m 47s
ESC 22: EMPEROR-POOLED: Clinical Benefits of SGLT2i in Heart Failure

Faiez Zannad

Watch time: 4m 44s
ESC 22: EMPEROR-Preserved & DELIVER Meta-Analysis: SGLT2is in HF

Muthiah Vaduganathan

Watch time: 5m 1s

Articles

Cardio-obstetrics in the CICU: An Introductory Guide

Jenna Skowronski

,

Eleanor Christenson

,

Kayle Shapero

,

Anaïs Hausvater

,

Ann Gage

,

Arun Jeyabalan

,

Kathryn Berlacher

,

Published:

25 March 2025

Citation:

US Cardiology Review 2025;19:e07.

DOI:

https://doi.org/10.15420/usc.2024.20
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 56
  • Downloads: Downloads 5
  • Read time: 21m 19s

COVID-19 Pandemic and Cardiovascular Disease

Aniket S Rali

,

Andrew J Sauer

,

Published:

25 March 2020

Citation:

US Cardiology Review 2020;14:e01.

DOI:

https://doi.org/10.15420/usc.2020.14
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1443
  • Downloads: Downloads 31
  • Citations: 10
  • Read time: 15m

Impact of Atrial Septal Defect on Hemodynamics

Saumil R Shah

,

Sergio Waxman

,

William H Gaasch

,

Citation:

US Cardiology Review 2017;11(2):72–4.

DOI:

https://doi.org/10.15420/ucs.2017:9:2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 5491
  • Downloads: Downloads 31
  • Citations: 5

Transvenous Phrenic Nerve Stimulation - A Novel Therapy for Central Sleep Apnea in Heart Failure

Sitaramesh Emani

,

William T Abraham

,

Citation:

US Cardiology 2012;9(1):53-6

DOI:

https://doi.org/10.15420/usc.2012.9.1.53
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1108
  • Downloads: Downloads 3
  • Citations: 1